Funding for this research was provided by:
Van Andel Research Institute
Novo Nordisk Fonden (NNF13OC0003435, NNF17CC0027852)
Kræftens Bekæmpelse (223-A13071-18-S68)
National Cancer Institute (R35CA209859)
Text and Data Mining valid from 2019-10-17
Received: 18 June 2019
Accepted: 5 September 2019
First Online: 17 October 2019
Ethics approval and consent to participate
: The study was approved by the regional ethics committee (H-16022249) and conducted in accordance with the declarations of Helsinki. All patients included in this study signed an informed consent form prior to participation.
: Not applicable.
: KG serves on advisory boards for Celgene, Otsuka Pharma, and Janssen pharma. PAJ is a paid consultant for ZYMO Corporation. ADØ, AN, HO, JBM, JL, JWH, IHD, LG, ML, NR, PH, and ZM declare no potential conflicts of interest.